Literature DB >> 3111489

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women.

M Petri, M Golbus, R Anderson, Q Whiting-O'Keefe, L Corash, D Hellmann.   

Abstract

In a controlled, prospective study of 44 consecutive women with idiopathic habitual abortion, only 5% had symptoms of rheumatic disease. Patients did not differ from control subjects in the frequency of positive results on tests for antinuclear antibody or anti-double-stranded DNA. Levels of C3 and C4 were higher in the habitual aborters. No patients had anti-Ro. The antiphospholipid antibody results were analyzed using 2 methods: the frequency of antiphospholipid antibodies was 9% by lupus anticoagulant using the Russell viper venom time (95% confidence interval 22-2.5) and 11% by anticardiolipin antibody assay (95% confidence interval 25-3.7), which was not significantly different from that in control subjects. However, the mean levels in the aborters (although within the normal range) were significantly higher than those in control subjects for anti-double-stranded DNA (P = 0.004), lupus anticoagulant (by Russell viper venom time; P = 0.05), and anticardiolipin antibody (P = 0.0007), when examined by multiple linear regression analysis corrected for age and concurrent pregnancy. Of the 3 patients with antiphospholipid antibodies and subsequent successful pregnancies, only 1 was treated with prednisone and aspirin. We conclude that, in the majority of women, subclinical lupus, anti-Ro, the lupus anticoagulant, and anticardiolipin antibodies are not associated with idiopathic habitual abortion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111489     DOI: 10.1002/art.1780300601

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors:  R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 2.  Pregnancy and antibodies to phospholipids.

Authors:  M J Walport
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

3.  Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.

Authors:  N J McHugh; D A Moye; I E James; M Sampson; P J Maddison
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

4.  Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.

Authors:  J L Vianna; H J Haga; P Tripathi; R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.

Authors:  J Font; R Cervera; A Lopez-Soto; L Pallares; X Bosch; S Ampurdanes; F J Casals; M Ingelmo
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

Review 6.  Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.

Authors:  A J Swaak; V Huysen; J C Nossent; R J Smeenk
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

7.  Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients.

Authors:  Y Wang; L Schrieber; M G Cohen; L Furphy; J Webb; T Chivers; K M Pollard
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  Prevalence of antiphospholipid antibodies in patients with fetal loss.

Authors:  H J Out; H W Bruinse; G C Christiaens; M van Vliet; J F Meilof; P G de Groot; R J Smeenk; R H Derksen
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

9.  Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss.

Authors:  M D Creagh; R G Malia; S M Cooper; A R Smith; S L Duncan; M Greaves
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

10.  Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study.

Authors:  G D Sebastiani; G Passiu; M Galeazzi; F Porzio; U Carcassi
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.